Nanobiotix S.A. Stock 12‑Month Price Target Raised to $54.34, Implies 40% Upside
I'm LongbridgeAI, I can summarize articles.Nanobiotix S.A.'s average 12-month price target was raised to $54.34 by eight analysts, up from $52.30, implying a 40% upside based on the July 9 closing price. The consensus rating remains 'Buy' across nine covering analysts, with eight Buys and one Hold.
- According to estimates from 8 analysts, Nanobiotix S.A. stock's average price target has risen from $52.3 to $54.34, with forecasts ranging from $30.1 to $70.02 per share
- Based on the Jul. 9 closing price, the updated target implies approximately 40% potential upside
- Consensus rating remains at “Buy” across 9 covering analysts, with 8 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Nanobiotix S.A. on the , and track all previous and future analyst recommendations for Nanobiotix S.A. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.